Veracyte in the news
May 25, 2023
Decipher Genomic Classifier Shows Prognostic Value in Intermediate-Risk Prostate Cancer
Urology Times
May 11, 2023
Veracyte Test Changes Chemotherapy Decisions in Breast Cancer
BioWorld
March 6, 2023
Veracyte Sees Revenue Growth in Oncology Classifiers, New Genomic Products, Global Expansion
LabPulse
March 1, 2023
How Single-Cancer Testing Could Revolutionize Diagnostics
Clinical Lab Products Magazine
February 22, 2023
Veracyte Ramps up Clinical Evidence Generation, Driving Gains in Prostate and Thyroid Test Business
GenomeWeb
December 15, 2022
Veracyte Announces Clinical Practice Data for Thyroid Cancer Classifier
LabPulse
October 20, 2022
Envisia Test May Help Identify ILD Patients with Progressing Disease
Pulmonary Fibrosis News